Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Linger

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Medical Science Educator|August 7, 2023
Integrating Foundational and Clinical Science Remotely by Combining Team-Based Learning and SimulationJoel Roberts, Qing Zhong, Rachel Linger
Cureus|November 21, 2025
Disrupting the Algorithm: The Role of Medical Professionals in TikTok's Post-traumatic Stress Disorder ConversationsLindsey Nichols, Jennifer Frazee, Brittany Quinn, et al.
Genes, Chromosomes & Cancer|October 19, 2007
Somatic KIT mutations occur predominantly in seminoma germ cell tumors and are not predictive of bilateral disease: report of 220 tumors and review of literatureJerome Coffey, Rachel Linger, Julia Pugh, et al.
Transfusion|October 26, 2022
The compound effect of irradiation and familial pseudohyperkalemia on potassium leak from red blood cellsAthinoula Meli, Rachel Linger, Christian J Stevens-Hernandez, et al.
Nature Genetics|June 15, 2010
Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancerClare Turnbull, Elizabeth A Rapley, Sheila Seal, et al.
Nature Genetics|June 2, 2009
A genome-wide association study of testicular germ cell tumorElizabeth A Rapley, Clare Turnbull, Ali Amin Al Olama, et al.
The Lancet. Gastroenterology & Hepatology|February 6, 2022
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control studyJames L Alexander, Nicholas A Kennedy, Hajir Ibraheim, et al.
The Lancet. Gastroenterology & Hepatology|September 11, 2022
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control studyJames L Alexander, Zhigang Liu, Diana Muñoz Sandoval, et al.
Human Mutation|September 29, 2019
Next-generation sequencing for the diagnosis of MYH9-RD: Predicting pathogenic variantsLoredana Bury, Karyn Megy, Jonathan C Stephens, et al.
Journal of Crohn'S & Colitis|November 9, 2023
Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or TofacitinibZhigang Liu, James L Alexander, Kai Yee Eng, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Medical Science Educator|August 7, 2023
Integrating Foundational and Clinical Science Remotely by Combining Team-Based Learning and SimulationJoel Roberts, Qing Zhong, Rachel Linger
Cureus|November 21, 2025
Disrupting the Algorithm: The Role of Medical Professionals in TikTok's Post-traumatic Stress Disorder ConversationsLindsey Nichols, Jennifer Frazee, Brittany Quinn, et al.
Genes, Chromosomes & Cancer|October 19, 2007
Somatic KIT mutations occur predominantly in seminoma germ cell tumors and are not predictive of bilateral disease: report of 220 tumors and review of literatureJerome Coffey, Rachel Linger, Julia Pugh, et al.
Transfusion|October 26, 2022
The compound effect of irradiation and familial pseudohyperkalemia on potassium leak from red blood cellsAthinoula Meli, Rachel Linger, Christian J Stevens-Hernandez, et al.
Nature Genetics|June 15, 2010
Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancerClare Turnbull, Elizabeth A Rapley, Sheila Seal, et al.
Nature Genetics|June 2, 2009
A genome-wide association study of testicular germ cell tumorElizabeth A Rapley, Clare Turnbull, Ali Amin Al Olama, et al.
The Lancet. Gastroenterology & Hepatology|February 6, 2022
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control studyJames L Alexander, Nicholas A Kennedy, Hajir Ibraheim, et al.
The Lancet. Gastroenterology & Hepatology|September 11, 2022
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control studyJames L Alexander, Zhigang Liu, Diana Muñoz Sandoval, et al.
Human Mutation|September 29, 2019
Next-generation sequencing for the diagnosis of MYH9-RD: Predicting pathogenic variantsLoredana Bury, Karyn Megy, Jonathan C Stephens, et al.
Journal of Crohn'S & Colitis|November 9, 2023
Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or TofacitinibZhigang Liu, James L Alexander, Kai Yee Eng, et al.
Pageof 2